0000914190-15-000343.txt : 20150819 0000914190-15-000343.hdr.sgml : 20150819 20150819164034 ACCESSION NUMBER: 0000914190-15-000343 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150817 FILED AS OF DATE: 20150819 DATE AS OF CHANGE: 20150819 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BETTERLEY LAURENCE L CENTRAL INDEX KEY: 0001243511 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 151064490 MAIL ADDRESS: STREET 1: C/O PLATO LEARNING, INC. STREET 2: 10801 NESBITT AVENUE SOUTH CITY: BLOOMINGTON STATE: MN ZIP: 55437 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-17 0001180145 Cardiovascular Systems Inc CSII 0001243511 BETTERLEY LAURENCE L 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Financial Officer Common Stock 2015-08-17 4 S 0 4726 24.0161 D 214901 D Common Stock 2015-08-18 4 S 0 3750 23.9849 D 211151 D Stock Option (right to buy) 8.75 2019-03-01 Common Stock 14234 14234 D In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.94 to $24.12 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.87 to $24.09 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully exercisable. /s/ Amanda Schmall as Attorney-in-Fact for Laurence L. Betterley pursuant to Power of Attorney previously filed. 2015-08-19